• Something wrong with this record ?

2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease

E. Mezeiova, J. Janockova, R. Andrys, O. Soukup, T. Kobrlova, L. Muckova, J. Pejchal, M. Simunkova, J. Handl, P. Micankova, J. Capek, T. Rousar, M. Hrabinova, E. Nepovimova, JL. Marco-Contelles, M. Valko, J. Korabecny

. 2021 ; 211 (-) : 113112. [pub] 20201218

Language English Country France

Document type Journal Article

Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks. The concept of "one drug, one target" has not generated any new drugs since 2004. The new era of drug development in the field of AD builds upon rationally designed multi-target directed ligands that can better address the complexity of AD. Herewith, we designed ten novel derivatives of 2-propargylamino-naphthoquinone. The biological evaluation of these compounds includes inhibition of monoamine oxidase A/B, inhibition of amyloid-beta aggregation, radical-scavenging, and metal-chelating properties. Some of the compounds possess low cytotoxicity profile with an anti-inflammatory ability in the lipopolysaccharide-stimulated cellular model. All these features warrant their further testing in the field of AD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019274
003      
CZ-PrNML
005      
20221024102112.0
007      
ta
008      
210728s2021 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmech.2020.113112 $2 doi
035    __
$a (PubMed)33360800
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Mezeiová, Eva $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $7 xx0277560
245    10
$a 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease / $c E. Mezeiova, J. Janockova, R. Andrys, O. Soukup, T. Kobrlova, L. Muckova, J. Pejchal, M. Simunkova, J. Handl, P. Micankova, J. Capek, T. Rousar, M. Hrabinova, E. Nepovimova, JL. Marco-Contelles, M. Valko, J. Korabecny
520    9_
$a Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks. The concept of "one drug, one target" has not generated any new drugs since 2004. The new era of drug development in the field of AD builds upon rationally designed multi-target directed ligands that can better address the complexity of AD. Herewith, we designed ten novel derivatives of 2-propargylamino-naphthoquinone. The biological evaluation of these compounds includes inhibition of monoamine oxidase A/B, inhibition of amyloid-beta aggregation, radical-scavenging, and metal-chelating properties. Some of the compounds possess low cytotoxicity profile with an anti-inflammatory ability in the lipopolysaccharide-stimulated cellular model. All these features warrant their further testing in the field of AD.
650    _2
$a Alzheimerova nemoc $x farmakoterapie $7 D000544
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a lidé $7 D006801
650    _2
$a naftochinony $x farmakologie $x terapeutické užití $7 D009285
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Janockova, Jana $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
700    1_
$a Andrys, Rudolf $u University Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
700    1_
$a Soukup, Ondrej $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
700    1_
$a Kobrlová, Tereza, $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $d 1991- $7 xx0277928
700    1_
$a Muckova, Lubica $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
700    1_
$a Pejchal, Jaroslav $u University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
700    1_
$a Simunkova, Miriama $u Slovak University of Technology, Faculty of Chemical and Food Technology, Radlinskeho 9, 812 37, Bratislava, Slovakia
700    1_
$a Handl, Jiri $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
700    1_
$a Micankova, Petra $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
700    1_
$a Capek, Jan $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
700    1_
$a Rousar, Tomas $u University of Pardubice, Faculty of Chemical Technology, Department of Biological and Biochemical Sciences, Studentska 573, 532 10, Pardubice, Czech Republic
700    1_
$a Hrabinova, Martina $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
700    1_
$a Nepovimova, Eugenie $u University Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
700    1_
$a Marco-Contelles, Jose Luis $u Institute of General Organic Chemistry, Laboratory of Medicinal Chemistry, Juan de La Cierva 3, 28006, Madrid, Spain. Electronic address: jlmarco@iqog.csic.es
700    1_
$a Valko, Marian $u Slovak University of Technology, Faculty of Chemical and Food Technology, Radlinskeho 9, 812 37, Bratislava, Slovakia. Electronic address: marian.valko@stuba.sk
700    1_
$a Korabecny, Jan $u University Hospital Hradec Kralove, Biomedical Research Centre, Sokolska 581, 500 05, Hradec Kralove, Czech Republic; University of Defence in Brno, Faculty of Military Health Sciences, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic. Electronic address: jan.korabecny@fnhk.cz
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 211, č. - (2021), s. 113112
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33360800 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20221024102110 $b ABA008
999    __
$a ok $b bmc $g 1690165 $s 1139720
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 211 $c - $d 113112 $e 20201218 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...